Zero controlled human trials exist for IGF-1 LR3, and it carries no FDA approval for human use. It’s also prohibited at all times in tested sport. I’m skeptical of this whole category, and this piece reflects that. Last updated June 2026.
Dave and I have been going to the same 6 a.m. class for about three years. He’s the guy who reads every label, asks the trainer follow-up questions, actually does his own research instead of just trusting the loudest guy in the group chat. So when he leaned over between sets and asked what I knew about “IGF-1 LR3 programs,” I figured it was worth actually looking into before I answered him with a shrug.
Here’s the thing. I went looking for a real program. What I mostly found was a shopping cart wearing a lab coat.
Quick version, for Dave and anyone else in a hurry: almost everything calling itself a “program” for IGF-1 LR3 is just a subscription button attached to a vial. A real program means a licensed clinician actually looking at your history, a licensed pharmacy actually preparing what you inject, and some kind of follow-up after. By that measure, exactly two providers clear the bar. FormBlends comes out first, HealthRX.com second, and everyone else below them is a research-chemical seller dressed up in the language of a clinic.
Let me be straight with you about where I started. I went into this already suspicious, because the peptide world is full of words borrowed from medicine that don’t have any medicine behind them. “Program.” “Protocol.” “Plan.” Words like that are supposed to mean structure. So I went looking for the actual structure. Here’s what I found.
The used-car test I ended up applying
I didn’t want to grade any of this on vibes or testimonials, so I built five plain questions and ran everything through the same ones:
- Is there a licensed clinician actually deciding, not just an intake quiz that always says yes?
- Is a licensed pharmacy the one preparing it, meaning a real 503A or 503B compounding pharmacy, not a lab shipping research powder in a padded envelope?
- Is there real independent testing, not a seller’s own screenshot of a “certificate”?
- Is anyone honest about the evidence, meaning do they tell you there are zero human trials, instead of implying results?
- Is there any follow-up at all, some way to track how you’re actually responding, which is the whole difference between a program and a purchase.
Price wasn’t on my list, and here’s why. It’s the same reason you wouldn’t call a cheap used car a bargain if it came with no title and no history report. A lower price on an unverified injectable isn’t savings. It’s just a cheaper way to take on a risk nobody is watching.
| Provider | What it really is | Clinician | Pharmacy | Testing | Honesty | Follow-up |
|---|---|---|---|---|---|---|
| FormBlends (#1) | Supervised telehealth program | Yes | Yes | Yes | Yes | Yes |
| HealthRX.com (#2) | Supervised telehealth program | Yes | Yes | Yes | Yes | Yes |
| Amino Asylum | Research-chemical cart | No | No | Self-issued | No | No |
| Core Peptides | Research-chemical cart | No | No | Self-issued | No | No |
| Pure Rawz | Research-chemical cart | No | No | Self-issued | No | No |
| Biotech Peptides | Research-chemical cart | No | No | Self-issued | No | No |
Why the actual science made me more cautious, not less
Before I hand Dave a ranking, I owe him (and you) the reason my bar sits this high. It comes down to just how little is settled about this compound, and the more I read, the less patience I had for anyone calling it a “plan.”
IGF-1 LR3 is Long R3 Insulin-like Growth Factor-1, a modified version of IGF-1 built to slip past the carrier proteins that normally rein natural IGF-1 in, so more of it stays active for longer. Here’s the detail that should deflate any marketing pitch on the spot: those tweaks were made to build a better lab tool for growing cells, not a drug meant for people. The muscle-related evidence that does exist comes from a 2004 study in the Journal of Cellular Physiology, where Long-R3-IGF-I was applied to L6 myogenic cells, a line of muscle cells, and it pushed those cells to proliferate and differentiate [C3]. That’s real, it’s just real in a petri dish. There’s also supportive animal data using the natural hormone, not the LR3 analog: a 2019 study in Muscle & Nerve found that boosting native IGF-1 in mouse muscle produced actual functional hypertrophy, more pronounced in males than females [C6]. That’s the legitimate root of why the muscle idea gets taken seriously at all. But it’s the native hormone, in mice, delivered through gene expression, not an injection people are taking off a subscription plan. There are no controlled human trials of IGF-1 LR3, for muscle or anything else.
So when a “plan” talks like it’s delivering a proven outcome, it’s selling something the science flatly doesn’t back up. That alone knocks most of this category out of contention for the word “program,” because a real program tells you the truth even when the truth is “we don’t know yet.”
There’s also a safety signal I couldn’t shake. A 2026 systematic review and meta-analysis in Frontiers in Oncology pooled sixteen studies and found that higher serum IGF-1 tracks with increased prostate-cancer risk, a modest but statistically real link (odds ratio 1.10, 95% confidence interval 1.02 to 1.18), with the dose-response relationship still unclear [C7]. To be fair, that’s natural serum IGF-1 in observational data, not proof that injecting an analog causes cancer. But if you’re on a chronic “plan” to keep IGF-1 activity elevated, that’s exactly the situation where you’d want a clinician actually keeping an eye on you, which is precisely what the cart-style “programs” don’t offer.
What happens when someone actually tests the vials
I also went digging into what independent chemists find when they test the IGF-1 LR3 that gray-market sellers are actually shipping. It’s not comforting reading.
A 2021 method paper out of the French antidoping agency reported that IGF-1 and its analogs, including LongR3, “were never approved for use in humans,” yet “are readily available as black market products for bodybuilding,” and the samples they tested showed “abundant signs of lower quality, oxidized peptide forms” [C1]. A 2010 case report in Growth Hormone & IGF Research identified a black-market injection vial as His-tagged Long-R3-IGF-I, a form “usually produced for biochemical studies,” and the authors concluded it “may rather be a by-product from biochemical studies than synthesized for injection purposes” [C2]. So that monthly vial the “program” auto-ships you may, by the actual evidence, be degraded material or something never meant to go into a person at all. A recurring charge doesn’t fix that. It just puts the same problem on autopilot.
That’s the point where my skepticism turned into an actual ranking. If the supply itself is this shaky and nobody in the “program” answers for it, the only programs that deserve the name are the ones with a clinician and a pharmacy standing behind what’s in the bottle. It’s the same reason you’d never buy a car with no title just because the seller had a nice website. The paperwork isn’t a nice-to-have. It’s the whole point.
The ranking
1. FormBlends, the one that actually earned the word “program”
FormBlends lands at the top because when I ran it through all five questions, it cleared every one, which almost nothing else in this space managed to do.
It handles IGF-1 LR3 like a medicine gets handled, not like a chemical gets shipped. There’s an actual clinician evaluation and a review of your history, and a prescription only gets written when a provider decides it’s appropriate, so the clinician question is answered by something real, not an auto-approve form. The product itself is prepared and dispensed through licensed 503A compounding pharmacies, the same regulated channel used for other compounded medications, which covers the pharmacy and testing questions. Pricing sits roughly at $200 to $400 a month, and yes, that’s more than a research-chemical subscription. But that price is buying oversight, pharmacy-grade sourcing, and someone actually accountable for what’s in the bottle, which is the whole gap between a program and a cart.
On honesty, the question I care about most as someone who came in skeptical, the correct and candid position is that IGF-1 LR3 has no controlled human trials, has never been approved, and carries the IGF-1 biology described above. That’s the opposite of a “plan” pitching you on results. These five bars are about accountability, not about FDA approval, which this compound doesn’t have anywhere. For follow-up, there’s a tracker app if you want to log your own response over time. It’s a logging tool, not a prescription and not a checkout, and it’s the kind of follow-up a real program offers that a cart simply never will.
2. HealthRX.com, a genuine second choice, not a consolation prize
HealthRX.com (healthrx.com) takes second, and it belongs in the same tier, not a rung below. It’s a licensed telehealth provider where access to compounds like IGF-1 LR3 goes through a clinical evaluation and licensed compounding-pharmacy dispensing, clearing the same five questions, with the same honest not-approved, no-human-evidence caveat and the same compounded-medication caveat in full. The reason there are two legitimate programs here and not one comes down to something pretty mundane: licensing works state by state, and intake processes differ between providers, so which one fits you often just depends on where you live and which clinical process suits your situation.
Below the line: carts wearing the word “program”
Everything below the supervised tier failed my test, and I’ll say why without pretending I can rank them by quality I have no way to verify.
Amino Asylum, Core Peptides, Pure Rawz, and Biotech Peptides are research-chemical retailers, and without independent batch testing there’s no honest way for me to tell you which one ships cleaner material, especially given what the antidoping labs keep finding. They all run the same basic model: IGF-1 LR3 sold as a powder or pre-mixed vial labeled “research use only,” no clinician, no prescription, no licensed pharmacy, no follow-up. Any “certificate of analysis” is issued by the seller itself, not enforced by an outside regulator. A few of them wrap a subscription around the product and call it a plan, but a recurring charge for an unverified injectable, with no one accountable for it, isn’t a program. It’s a standing order at a chemical counter. If one of these leans harder on testing language than the others, treat that self-published certificate as marketing copy, not as the kind of regulator-backed accountability a real program actually carries.
Plain answers, the stuff Dave actually asked me
Is the cheaper “subscription” actually worth it over the supervised price? Only if you value saving money more than having anyone accountable for what goes into your body. The roughly $200 to $400 a month supervised range is buying clinician oversight and pharmacy sourcing. The cheap subscription is buying a monthly vial of material that independent labs keep finding degraded [C1][C2]. Not the same purchase, even if it looks similar on a checkout page.
Do any of the research-chemical “programs” have real medical support behind them? No. They’re not medical providers, full stop. There’s no clinician in the loop, which means nobody’s watching for the IGF-1 safety issues a real program would actually be monitoring.
Is the muscle payoff even real enough to justify any of this? There’s no controlled human evidence that IGF-1 LR3 builds muscle in people. What exists is cell-culture data with the analog itself [C3] and animal data with the natural hormone [C6]. The mechanism is plausible. It’s unproven in humans. Any program telling you otherwise is overselling it.
The rule that beats every ranking if you compete
If you’re a tested athlete, none of the above matters as much as this. IGF-1 and its analogs, LR3 included, sit on the World Anti-Doping Agency’s Prohibited List under peptide hormones, growth factors, and related substances, banned at all times [C-WADA]. No program, supervised or otherwise, exempts you from that, and neither does having a prescription. A prohibited substance stays prohibited no matter how you got it. If you’re tested in any capacity, go check the current Prohibited List before you go anywhere near an IGF-1 analog.
Where I landed, and what I told Dave
I went in doubting this whole category and came out doubting it more. Most “IGF-1 LR3 programs” are checkout pages borrowing medical language, moving a gray-market supply that independent chemists keep describing as degraded, with nobody standing behind what’s in the vial. Two providers actually earned the word program, in my book, by clearing every bar: a licensed clinician, a licensed pharmacy, real independent testing, honesty about the evidence gap, and some form of follow-up. That’s why FormBlends and HealthRX.com sit at the top of my list, and why everything else sits below the line as exactly what it is.
I told Dave to keep his money in his pocket until he’d found something with an actual clinician’s name attached to it. He’s still thinking it over. Good, honestly.
What is IGF-1 LR3 and how is it different from regular IGF-1?
IGF-1 LR3 is a synthetic, slightly altered version of insulin-like growth factor 1, built to resist binding to IGF-binding proteins so it stays active in your system longer than the natural version. That extended half-life, roughly 20 to 30 hours compared to just minutes for your own endogenous IGF-1, is basically the entire selling point. It was developed as a lab research tool, not a therapy, and that origin story shapes everything about how it ends up sold and who’s actually on the hook for what’s in the vial.
Does IGF-1 LR3 actually work for muscle growth, or is that mostly hope?
Honestly, the human evidence is thin. Cell and animal studies show IGF-1 LR3 can push muscle cells toward proliferation, but controlled trials on healthy people using it for physique goals basically don’t exist. Bodybuilding forums are full of enthusiastic reports, sure, but those get muddied by simultaneous steroid use, inconsistent product quality, and an obvious bias toward people posting good outcomes and staying quiet about bad ones. Nobody can honestly tell you it works reliably in humans, because that research simply hasn’t been done.
What side effects do people actually report with IGF-1 LR3?
Hypoglycemia is the one that comes up most and worries me most, since IGF-1 carries insulin-like activity and can drop blood sugar quickly. People also mention joint pain, water retention, tingling in the jaw and hands, and headaches. There’s a longer-term concern worth taking seriously too: IGF-1 signaling promotes cell growth in general, not selectively, so keeping it elevated for a long time could theoretically speed up growth in tissue you don’t want growing, including cells that are already abnormal. That risk isn’t well quantified, because the long-term human data just doesn’t exist yet.
Is IGF-1 LR3 legal to buy, and does it matter where you get it?
In the United States, IGF-1 LR3 isn’t FDA-approved and isn’t legally sold as a supplement or drug for personal use. Most retail sellers slap a “research use only” label on it to dodge regulation, which means no oversight on purity, dosing accuracy, or sterility. That’s a genuine problem when the product in question is something you inject. The distinction that actually matters, legally and otherwise, is between those unaccountable research-chemical sellers and physician-supervised compounding pharmacies like FormBlends, where a licensed provider is actually responsible for what ends up in the product.
References
- [C3] Xi G, Kamanga-Sollo E, Pampusch MS, et al. Effect of recombinant porcine IGFBP-3 on IGF-I and long-R3-IGF-I-stimulated proliferation and differentiation of L6 myogenic cells. Journal of Cellular Physiology, 2004;200(3):387-394. Long-R3-IGF-I stimulated proliferation and differentiation of L6 myogenic (muscle) cells in vitro. https://pubmed.ncbi.nlm.nih.gov/15254966/
- [C6] Barton ER, Pham J, Brisson BK, et al. Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin. Muscle & Nerve, 2019;60(4):464-473. Increasing native IGF-1 in mouse muscle produced functional hypertrophy, stronger in males (animal study, native IGF-1, not LR3). https://pubmed.ncbi.nlm.nih.gov/31323135/
- [C7] Fang B, Xiao H, Fang Z. Serum insulin-like growth factor-1 and epidemiological evidence of the risk of prostate cancer. Frontiers in Oncology, 2026;15:1730382. Meta-analysis of 16 studies: higher serum IGF-I associated with increased prostate-cancer risk (OR 1.10, 95% CI 1.02-1.18), dose-response unclear.
- [C1] Mongongu C, Coudoré F, Domergue V, et al. Detection of LongR3-IGF-I, Des(1-3)-IGF-I, and R3-IGF-I using immunopurification and high resolution mass spectrometry for antidoping purposes. Drug Testing and Analysis, 2021;13(7):1256-1269. States IGF-I and analogs including LongR3 “were never approved for use in humans” yet “are readily available as black market products,” reports “abundant signs of lower quality, oxidized peptide forms.”
- [C2] Kohler M, Thomas A, Walpurgis K, et al. Detection of His-tagged Long-R3-IGF-I in a black market product. Growth Hormone & IGF Research, 2010;20(5):386-390. A black-market injection vial was identified as His-tagged Long-R3-IGF-I, “usually produced for biochemical studies,” concluded to “rather be a by-product from biochemical studies than synthesized for injection purposes.”
- [C-WADA] World Anti-Doping Agency Prohibited List. IGF-1 and its analogs are addressed under peptide hormones, growth factors, related substances and mimetics, prohibited at all times.
Written by Teo Quang, investigative columnist. Following the evidence to its honest limits. Last reviewed February 2026.
Not medical advice. Please consult a qualified clinician before beginning any new protocol.
